Related Experiment Video
Updated: Apr 18, 2026
Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
Published on: April 12, 2024
Association between skin and joint involvement in patients with psoriatic arthritis treated with adalimumab: analysis
Diamant Thaçi1, Frank Behrens, Gerd Greger
1Comprehensive Center for Inflammation Medicine, University Hospital Schleswig-Holstein Campus Lübeck, Lübeck, Germany.
Background:
The association between skin and joint manifestations in patients with psoriatic arthritis (PsA) requires further characterization.
Objective:
We evaluated the association between severity of skin disease and joint involvement and the effectiveness and safety of adalimumab in PsA patients by baseline psoriasis severity.
Methods:
Descriptive statistics and regression analyses were used to evaluate data from 1,918 PsA patients starting adalimumab treatment. Subgroup analyses were conducted on patients empirically grouped by baseline target lesion score as a marker of psoriasis severity.
Results:
Psoriasis severity was not associated with joint manifestations at baseline or after 12 months of treatment. All subgroups showed improvements in skin and joints during therapy, and adalimumab was safe and well tolerated in all subgroups.
Conclusion:
The severity of skin manifestations does not correlate with the severity of joint disease in PsA patients; even patients with mild skin disease may have extensive musculoskeletal involvement.
More Related Videos
08:51Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
05:46A Proinflammatory, Degenerative Organ Culture Model to Simulate Early-Stage Intervertebral Disc Disease.
Published on: February 14, 2021